203 related articles for article (PubMed ID: 35478369)
21. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.
Walsh CS; Blum A; Walts A; Alsabeh R; Tran H; Koeffler HP; Karlan BY
Gynecol Oncol; 2010 Mar; 116(3):516-21. PubMed ID: 20034658
[TBL] [Abstract][Full Text] [Related]
22. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature.
Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello FM
Fam Cancer; 2022 Jan; 21(1):57-67. PubMed ID: 33426601
[TBL] [Abstract][Full Text] [Related]
23. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
24. Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results.
Ryan N; Wall J; Crosbie EJ; Arends M; Bosse T; Arif S; Faruqi A; Frayling I; Ganesan R; Hock YL; McMahon R; Manchanda R; McCluggage WG; Mukonoweshuro P; van Schalkwyk G; Side L; Smith JH; Tanchel B; Evans DG; Gilks CB; Singh N
Histopathology; 2019 Dec; 75(6):813-824. PubMed ID: 31310679
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer.
Hodan R; Kingham K; Cotter K; Folkins AK; Kurian AW; Ford JM; Longacre T
Cancer Med; 2021 Feb; 10(3):1012-1017. PubMed ID: 33369189
[TBL] [Abstract][Full Text] [Related]
26. Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil.
Cossio SL; Koehler-Santos P; Pessini SA; Mónego H; Edelweiss MI; Meurer L; Errami A; Coffa J; Bock H; Saraiva-Pereira ML; Ashton-Prolla P; Prolla JC
Fam Cancer; 2010 Jun; 9(2):131-9. PubMed ID: 19821155
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years.
Leenen CH; van Lier MG; van Doorn HC; van Leerdam ME; Kooi SG; de Waard J; Hoedemaeker RF; van den Ouweland AM; Hulspas SM; Dubbink HJ; Kuipers EJ; Wagner A; Dinjens WN; Steyerberg EW
Gynecol Oncol; 2012 May; 125(2):414-20. PubMed ID: 22306203
[TBL] [Abstract][Full Text] [Related]
28. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers.
Kim SR; Tone A; Kim R; Cesari M; Clarke B; Hart T; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE; Eiriksson L
Int J Gynecol Cancer; 2022 Jul; 32(7):891-898. PubMed ID: 35012974
[TBL] [Abstract][Full Text] [Related]
29. Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas.
Clarke BA; Cooper K
Adv Anat Pathol; 2012 Jul; 19(4):231-8. PubMed ID: 22692286
[TBL] [Abstract][Full Text] [Related]
30. Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer.
Bruegl AS; Kernberg A; Broaddus RR
Adv Anat Pathol; 2017 Nov; 24(6):372-378. PubMed ID: 28820751
[TBL] [Abstract][Full Text] [Related]
31. Molecular changes preceding endometrial and ovarian cancer: a study of consecutive endometrial specimens from Lynch syndrome surveillance.
Niskakoski A; Pasanen A; Lassus H; Renkonen-Sinisalo L; Kaur S; Mecklin JP; Bützow R; Peltomäki P
Mod Pathol; 2018 Aug; 31(8):1291-1301. PubMed ID: 29588532
[TBL] [Abstract][Full Text] [Related]
32. Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary.
Vierkoetter KR; Ayabe AR; VanDrunen M; Ahn HJ; Shimizu DM; Terada KY
Gynecol Oncol; 2014 Oct; 135(1):81-4. PubMed ID: 25093288
[TBL] [Abstract][Full Text] [Related]
33. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
34. Identifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years.
Anagnostopoulos A; McKay VH; Cooper I; Campbell F; Greenhalgh L; Kirwan J
Int J Gynecol Cancer; 2017 Jun; 27(5):931-937. PubMed ID: 28498244
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
[TBL] [Abstract][Full Text] [Related]
36. Mismatch repair deficiency testing in clinical practice.
Buza N; Ziai J; Hui P
Expert Rev Mol Diagn; 2016; 16(5):591-604. PubMed ID: 26895074
[TBL] [Abstract][Full Text] [Related]
37. Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and Consequences.
Leskela S; Romero I; Cristobal E; Pérez-Mies B; Rosa-Rosa JM; Gutierrez-Pecharroman A; Caniego-Casas T; Santón A; Ojeda B; López-Reig R; Palacios-Berraquero ML; García Á; Ibarra J; Hakim S; Guarch R; López-Guerrero JA; Poveda A; Palacios J
Am J Surg Pathol; 2020 May; 44(5):649-656. PubMed ID: 32294063
[TBL] [Abstract][Full Text] [Related]
38. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
39. Complete Response to Immune Checkpoint Inhibition in a Platinum Resistant Primary Ovarian Cancer Patient With Lynch Syndrome: A Case Report and Review of the Literature.
Chinczewski L; Feldhaus FW; Schmitt W; Braicu I; Roser E; Sehouli J
Anticancer Res; 2023 Apr; 43(4):1655-1662. PubMed ID: 36974818
[TBL] [Abstract][Full Text] [Related]
40. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
